Latest news
Ocular Therapeutix Options for New Hires Carry $8.40 Price - Stock TitanStock Titan · Fri, 07 Aug 2026 20:05:00 GMTKiora Starts Enrollment in 100-Microgram Retinitis Pigmentosa Cohort - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTAbout $300M Cullgen deal adds cancer candidates to Gyre's pipeline - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTCorvus Eczema Trial Is Expected to Enroll About 200 Patients - Stock TitanStock Titan · Thu, 06 Aug 2026 23:04:17 GMTMiNK's First agenT-797 Patients Were Alive With Improved Oxygenation at Day 28 - Stock TitanStock Titan · Thu, 06 Aug 2026 16:00:00 GMTOne knee injection study followed pain and function for 2 years - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTKodiak's Trial Tests KSI-101 for Macular Edema Secondary to Inflammation - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMTEvotec and Odyssey Pair AI With Lab Tests for Immune Diseases - Stock TitanStock Titan · Thu, 06 Aug 2026 08:18:30 GMT